Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

NIH Director: Alzheimer's a huge priority for us

Eli Lilly is the best stock in pharma: Trader

Eli Lilly launches 'LillyDirect': What this means for the pharma space

Full interview with Eli Lilly CEO David Ricks on emergency use authorization of Covid-19 antibody treatment

Eli Lilly CEO: We see a path to have an Alzheimer's disease-modifying drug

Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

Eli Lilly CEO on the company's Q2 earnings and core business performance

Analyst breaks down what is behind Eli Lilly's Q3 earnings miss